Breakthrough Filamentous Fungal Infections in Pediatric Hematopoetic Stem Cell Transplant and Oncology Patients Receiving Caspofungin
BACKGROUND: Caspofungin is an echinocandin class antifungal medication that is commonly used empirically in immunocompromised patients at high risk for invasive fungal disease.
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
Online Access: | http://dx.doi.org/10.1155/2012/957973 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832558906579091456 |
---|---|
author | Shaun K Morris Upton D Allen Sumit Gupta Susan E Richardson |
author_facet | Shaun K Morris Upton D Allen Sumit Gupta Susan E Richardson |
author_sort | Shaun K Morris |
collection | DOAJ |
description | BACKGROUND: Caspofungin is an echinocandin class antifungal medication that is commonly used empirically in immunocompromised patients at high risk for invasive fungal disease. |
format | Article |
id | doaj-art-f8b7c4e526224fccb165d2307bd315cf |
institution | Kabale University |
issn | 1712-9532 |
language | English |
publishDate | 2012-01-01 |
publisher | Wiley |
record_format | Article |
series | Canadian Journal of Infectious Diseases and Medical Microbiology |
spelling | doaj-art-f8b7c4e526224fccb165d2307bd315cf2025-02-03T01:31:18ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1712-95322012-01-0123417918210.1155/2012/957973Breakthrough Filamentous Fungal Infections in Pediatric Hematopoetic Stem Cell Transplant and Oncology Patients Receiving CaspofunginShaun K Morris0Upton D Allen1Sumit Gupta2Susan E Richardson3Division of Infectious Diseases, Toronto, Ontario, CanadaDivision of Infectious Diseases, Toronto, Ontario, CanadaDivision of Haematology and Oncology, Department of Pediatrics, Toronto, Ontario, CanadaDivision of Microbiology, The Hospital for Sick Children, Toronto, Ontario, CanadaBACKGROUND: Caspofungin is an echinocandin class antifungal medication that is commonly used empirically in immunocompromised patients at high risk for invasive fungal disease.http://dx.doi.org/10.1155/2012/957973 |
spellingShingle | Shaun K Morris Upton D Allen Sumit Gupta Susan E Richardson Breakthrough Filamentous Fungal Infections in Pediatric Hematopoetic Stem Cell Transplant and Oncology Patients Receiving Caspofungin Canadian Journal of Infectious Diseases and Medical Microbiology |
title | Breakthrough Filamentous Fungal Infections in Pediatric Hematopoetic Stem Cell Transplant and Oncology Patients Receiving Caspofungin |
title_full | Breakthrough Filamentous Fungal Infections in Pediatric Hematopoetic Stem Cell Transplant and Oncology Patients Receiving Caspofungin |
title_fullStr | Breakthrough Filamentous Fungal Infections in Pediatric Hematopoetic Stem Cell Transplant and Oncology Patients Receiving Caspofungin |
title_full_unstemmed | Breakthrough Filamentous Fungal Infections in Pediatric Hematopoetic Stem Cell Transplant and Oncology Patients Receiving Caspofungin |
title_short | Breakthrough Filamentous Fungal Infections in Pediatric Hematopoetic Stem Cell Transplant and Oncology Patients Receiving Caspofungin |
title_sort | breakthrough filamentous fungal infections in pediatric hematopoetic stem cell transplant and oncology patients receiving caspofungin |
url | http://dx.doi.org/10.1155/2012/957973 |
work_keys_str_mv | AT shaunkmorris breakthroughfilamentousfungalinfectionsinpediatrichematopoeticstemcelltransplantandoncologypatientsreceivingcaspofungin AT uptondallen breakthroughfilamentousfungalinfectionsinpediatrichematopoeticstemcelltransplantandoncologypatientsreceivingcaspofungin AT sumitgupta breakthroughfilamentousfungalinfectionsinpediatrichematopoeticstemcelltransplantandoncologypatientsreceivingcaspofungin AT susanerichardson breakthroughfilamentousfungalinfectionsinpediatrichematopoeticstemcelltransplantandoncologypatientsreceivingcaspofungin |